Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation
| dc.contributor.author | Nyce, Jonathan W. | |
| dc.date.accessioned | 2016-02-05T16:05:27Z | |
| dc.date.available | 2016-02-05T16:05:27Z | |
| dc.date.issued | 2000-03-21 | |
| dc.description.abstract | A DNA comprises an oligonucleotide antisense to mRNA encoding an adenosine A.sub.1 or A.sub.3 receptor. The oligo is provided as a composition, various formulations, a capsule, and cartridge and in the form of a kit. The oligonucleotide of the invention is effective for reducing bronchoconstriction and/or allergy, and may be administered to a subject to treat respiratory ailments such as asthma and other conditions associated with the expression of adenosine receptors. | en_US |
| dc.identifier.other | U.S Patent No. 6,040,296 | |
| dc.identifier.uri | http://hdl.handle.net/10342/5168 | |
| dc.title | Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation | en_US |
| dc.type | Patent | en_US |
Files
Original bundle
1 - 1 of 1